Birdwatch Note
2024-11-13 18:59:31 UTC - MISINFORMED_OR_POTENTIALLY_MISLEADING
Rien dans les données montrées ne précise si les patients étaient vaccinés ou non. Par contre, l'atteinte rénale sévère est une complication fréquente du COVID et concerne 20 à 40% des patients admis en réanimation https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30229-0/fulltext
Written by 51D5BF872806600EBE195059D4DA6775990893F9B83C8320BF10DB3D003D78AF
Participant Details
Original Tweet
Tweet embedding is no longer reliably available, due to the platform's instability (in terms of both technology and policy). If the Tweet still exists, you can view it here: https://twitter.com/foo_bar/status/1856245117595611405
Please note, though, that you may need to have your own Twitter account to access that page. I am currently exploring options for archiving Tweet data in a post-API context.
All Information
- ID - 1856773906700333492
- noteId - 1856773906700333492
- participantId -
- noteAuthorParticipantId - 51D5BF872806600EBE195059D4DA6775990893F9B83C8320BF10DB3D003D78AF
- createdAtMillis - 1731524371205
- tweetId - 1856245117595611405
- classification - MISINFORMED_OR_POTENTIALLY_MISLEADING
- believable -
- harmful -
- validationDifficulty -
- misleadingOther - 0
- misleadingFactualError - 1
- misleadingManipulatedMedia - 0
- misleadingOutdatedInformation - 0
- misleadingMissingImportantContext - 0
- misleadingUnverifiedClaimAsFact - 0
- misleadingSatire - 0
- notMisleadingOther - 0
- notMisleadingFactuallyCorrect - 0
- notMisleadingOutdatedButNotWhenWritten - 0
- notMisleadingClearlySatire - 0
- notMisleadingPersonalOpinion - 0
- trustworthySources - 1
- summary
- Rien dans les données montrées ne précise si les patients étaient vaccinés ou non. Par contre, l'atteinte rénale sévère est une complication fréquente du COVID et concerne 20 à 40% des patients admis en réanimation https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(20)30229-0/fulltext
Note Ratings
| rated at | rated by | |
| 2024-11-13 14:00:20 -0600 | Rating Details | |
| 2024-11-13 13:00:24 -0600 | Rating Details | |
| 2024-11-13 13:31:44 -0600 | Rating Details | |
| 2024-11-13 13:03:46 -0600 | Rating Details |